Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin America
ABSTRACT: Rationale Treatment of drug hypersensitivity reactions is usually managed by general practitioners not specifically trained in Allergology. The situation of patients thus treated in different Latin American countries is described, as evaluated in a first visit to a specialist. Methods A de...
- Autores:
-
Cardona Villa, Ricardo
Ramírez Giraldo, Ruth
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2014
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/45387
- Acceso en línea:
- https://hdl.handle.net/10495/45387
- Palabra clave:
- Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
Drug-Related Side Effects and Adverse Reactions
Hipersensibilidad a las Drogas
Drug Hypersensitivity
Estudios Transversales
Cross-Sectional Studies
América Latina
Latin America
https://id.nlm.nih.gov/mesh/D064420
https://id.nlm.nih.gov/mesh/D004342
https://id.nlm.nih.gov/mesh/D003430
https://id.nlm.nih.gov/mesh/D007843
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
| id |
UDEA2_872a8487fde8caa7cb53d8370e289201 |
|---|---|
| oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/45387 |
| network_acronym_str |
UDEA2 |
| network_name_str |
Repositorio UdeA |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin America |
| title |
Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin America |
| spellingShingle |
Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin America Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Drug-Related Side Effects and Adverse Reactions Hipersensibilidad a las Drogas Drug Hypersensitivity Estudios Transversales Cross-Sectional Studies América Latina Latin America https://id.nlm.nih.gov/mesh/D064420 https://id.nlm.nih.gov/mesh/D004342 https://id.nlm.nih.gov/mesh/D003430 https://id.nlm.nih.gov/mesh/D007843 |
| title_short |
Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin America |
| title_full |
Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin America |
| title_fullStr |
Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin America |
| title_full_unstemmed |
Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin America |
| title_sort |
Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin America |
| dc.creator.fl_str_mv |
Cardona Villa, Ricardo Ramírez Giraldo, Ruth |
| dc.contributor.author.none.fl_str_mv |
Cardona Villa, Ricardo Ramírez Giraldo, Ruth |
| dc.contributor.researchgroup.spa.fl_str_mv |
Grupo de Alergología Clínica y Experimental (GACE) |
| dc.subject.decs.none.fl_str_mv |
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Drug-Related Side Effects and Adverse Reactions Hipersensibilidad a las Drogas Drug Hypersensitivity Estudios Transversales Cross-Sectional Studies América Latina Latin America |
| topic |
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Drug-Related Side Effects and Adverse Reactions Hipersensibilidad a las Drogas Drug Hypersensitivity Estudios Transversales Cross-Sectional Studies América Latina Latin America https://id.nlm.nih.gov/mesh/D064420 https://id.nlm.nih.gov/mesh/D004342 https://id.nlm.nih.gov/mesh/D003430 https://id.nlm.nih.gov/mesh/D007843 |
| dc.subject.meshuri.none.fl_str_mv |
https://id.nlm.nih.gov/mesh/D064420 https://id.nlm.nih.gov/mesh/D004342 https://id.nlm.nih.gov/mesh/D003430 https://id.nlm.nih.gov/mesh/D007843 |
| description |
ABSTRACT: Rationale Treatment of drug hypersensitivity reactions is usually managed by general practitioners not specifically trained in Allergology. The situation of patients thus treated in different Latin American countries is described, as evaluated in a first visit to a specialist. Methods A descriptive cross sectional study using a modified ENDA questionnaire was implemented in 18 allergology units from 10 different Latin American countries, reporting patients assisted for hypersensitivity adverse drug reactions in the last year. Severity was graded as mild, moderate and severe. Results 453 patients were evaluated. Skin prick tests were done in 13% of patients, and specific IgE in 8%. Drug provocation tests were performed in 159 patients (35%), being positive in 49. Thirty-six percent of the reactions were mild, 44% moderate and 20% severe; Forty-six percent occurred during the first hour of taking the causative drug, 36% between 1 and 24 hours, and 18% after 24 hours. Fifty-seven percent were treated in the ED, 20% by an allergist, 8% by a general practitioner, 6% were self medicated, and 7% received no medication. Forty-five percent of the patients received systemic steroids and antihistamines, 24% antihistamines, and 10% only systemic steroids. Eighty-nine patients had severe reactions, but only 28 received epinephrine. Conclusions More than half of the reactions were treated in the ED, antihistamines were given in 2/3 cases, and steroids in more than half. Epinephrine was administered only in 31% of the patients having severe reactions. Medical education oriented to general and emergency care practitioners in Latin America should focus on this topic. |
| publishDate |
2014 |
| dc.date.issued.none.fl_str_mv |
2014 |
| dc.date.accessioned.none.fl_str_mv |
2025-03-08T16:17:29Z |
| dc.date.available.none.fl_str_mv |
2025-03-08T16:17:29Z |
| dc.type.spa.fl_str_mv |
Artículo de revista |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ARTDIV |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
http://purl.org/coar/resource_type/c_6501 |
| status_str |
publishedVersion |
| dc.identifier.issn.none.fl_str_mv |
0091-6749 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/45387 |
| dc.identifier.doi.none.fl_str_mv |
10.1016/j.jaci.2012.12.1276 |
| dc.identifier.eissn.none.fl_str_mv |
1097-6825 |
| identifier_str_mv |
0091-6749 10.1016/j.jaci.2012.12.1276 1097-6825 |
| url |
https://hdl.handle.net/10495/45387 |
| dc.language.iso.spa.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
J. Allergy Clin. Immunol. |
| dc.relation.citationendpage.spa.fl_str_mv |
172 |
| dc.relation.citationissue.spa.fl_str_mv |
Suplemento 2 |
| dc.relation.citationstartpage.spa.fl_str_mv |
172 |
| dc.relation.citationvolume.spa.fl_str_mv |
131 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
Journal of Allergy and Clinical Immunology |
| dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ https://creativecommons.org/licenses/by-nc-nd/4.0/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.extent.spa.fl_str_mv |
1 página |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Elsevier |
| dc.publisher.place.spa.fl_str_mv |
San Luis, Estados Unidos |
| institution |
Universidad de Antioquia |
| bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstreams/de7a5d58-4bd4-461e-8621-cca171d6a7ce/download https://bibliotecadigital.udea.edu.co/bitstreams/3045196b-3347-4808-8359-0813f74c0112/download https://bibliotecadigital.udea.edu.co/bitstreams/39fedfca-df8a-4f5f-b46c-6e55a1d5baed/download https://bibliotecadigital.udea.edu.co/bitstreams/ae68a713-ea40-4378-870a-19698be1a326/download https://bibliotecadigital.udea.edu.co/bitstreams/5e37981e-8d9d-4870-9b9d-fbd79f077503/download |
| bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 bbc0d934beeaae7a31036e0e77525bdb b88b088d9957e670ce3b3fbe2eedbc13 a6adc4fc916da06f684fd597e9fa5e2f e30853877bf34070b1cadcabc5e2a119 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional de la Universidad de Antioquia |
| repository.mail.fl_str_mv |
aplicacionbibliotecadigitalbiblioteca@udea.edu.co |
| _version_ |
1851052147569852416 |
| spelling |
Cardona Villa, RicardoRamírez Giraldo, RuthGrupo de Alergología Clínica y Experimental (GACE)2025-03-08T16:17:29Z2025-03-08T16:17:29Z20140091-6749https://hdl.handle.net/10495/4538710.1016/j.jaci.2012.12.12761097-6825ABSTRACT: Rationale Treatment of drug hypersensitivity reactions is usually managed by general practitioners not specifically trained in Allergology. The situation of patients thus treated in different Latin American countries is described, as evaluated in a first visit to a specialist. Methods A descriptive cross sectional study using a modified ENDA questionnaire was implemented in 18 allergology units from 10 different Latin American countries, reporting patients assisted for hypersensitivity adverse drug reactions in the last year. Severity was graded as mild, moderate and severe. Results 453 patients were evaluated. Skin prick tests were done in 13% of patients, and specific IgE in 8%. Drug provocation tests were performed in 159 patients (35%), being positive in 49. Thirty-six percent of the reactions were mild, 44% moderate and 20% severe; Forty-six percent occurred during the first hour of taking the causative drug, 36% between 1 and 24 hours, and 18% after 24 hours. Fifty-seven percent were treated in the ED, 20% by an allergist, 8% by a general practitioner, 6% were self medicated, and 7% received no medication. Forty-five percent of the patients received systemic steroids and antihistamines, 24% antihistamines, and 10% only systemic steroids. Eighty-nine patients had severe reactions, but only 28 received epinephrine. Conclusions More than half of the reactions were treated in the ED, antihistamines were given in 2/3 cases, and steroids in more than half. Epinephrine was administered only in 31% of the patients having severe reactions. Medical education oriented to general and emergency care practitioners in Latin America should focus on this topic.COL00595671 páginaapplication/pdfengElsevierSan Luis, Estados Unidoshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin AmericaArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTDIVhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionEfectos Colaterales y Reacciones Adversas Relacionados con MedicamentosDrug-Related Side Effects and Adverse ReactionsHipersensibilidad a las DrogasDrug HypersensitivityEstudios TransversalesCross-Sectional StudiesAmérica LatinaLatin Americahttps://id.nlm.nih.gov/mesh/D064420https://id.nlm.nih.gov/mesh/D004342https://id.nlm.nih.gov/mesh/D003430https://id.nlm.nih.gov/mesh/D007843J. Allergy Clin. Immunol.172Suplemento 2172131Journal of Allergy and Clinical ImmunologyPublicationLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/de7a5d58-4bd4-461e-8621-cca171d6a7ce/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADORIGINALCardonaRicardo_2013_Management_Adverse_Drug.pdfCardonaRicardo_2013_Management_Adverse_Drug.pdfArtículo de divulgaciónapplication/pdf41926https://bibliotecadigital.udea.edu.co/bitstreams/3045196b-3347-4808-8359-0813f74c0112/downloadbbc0d934beeaae7a31036e0e77525bdbMD51trueAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/39fedfca-df8a-4f5f-b46c-6e55a1d5baed/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADTEXTCardonaRicardo_2013_Management_Adverse_Drug.pdf.txtCardonaRicardo_2013_Management_Adverse_Drug.pdf.txtExtracted texttext/plain8620https://bibliotecadigital.udea.edu.co/bitstreams/ae68a713-ea40-4378-870a-19698be1a326/downloada6adc4fc916da06f684fd597e9fa5e2fMD56falseAnonymousREADTHUMBNAILCardonaRicardo_2013_Management_Adverse_Drug.pdf.jpgCardonaRicardo_2013_Management_Adverse_Drug.pdf.jpgGenerated Thumbnailimage/jpeg17554https://bibliotecadigital.udea.edu.co/bitstreams/5e37981e-8d9d-4870-9b9d-fbd79f077503/downloade30853877bf34070b1cadcabc5e2a119MD57falseAnonymousREAD10495/45387oai:bibliotecadigital.udea.edu.co:10495/453872025-03-26 17:41:22.205http://creativecommons.org/licenses/by-nc-nd/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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 |
